DAVID ALMA HARRIS, CSW
Social Work at 26 St, Ogden, UT

License number
Utah 54633133502
Category
Social Work
Type
Social Worker
Address
Address
237 26Th St, Ogden, UT 84401
Phone
(801) 778-6856

Professional information

David Harris Photo 1

David Harris, Ogden UT - Teacher

Specialties:
Criminal Justice
Work:
Weber State University - Ogden UT


David Harris Photo 2

System For Noninvasive Hematocrit Monitoring

US Patent:
6681128, Jan 20, 2004
Filed:
Jun 13, 2001
Appl. No.:
09/879192
Inventors:
Robert R. Steuer - Pleasant View UT
David H. Harris - Ogden UT
Assignee:
Hema Metrics, Inc. - Kaysville UT
International Classification:
A61B 500
US Classification:
600322, 600310, 600330
Abstract:
A system determines heamtocrit transcutaneously and noninvasively. Disclosed are a finger clip assembly and an earlobe clip assembly, each including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least two, and preferably three, predetermined wavelengths of light are assed onto or through body tissues such as the finger, earlobe, or scalp, etc. and the extinction of each wavelength is detected. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If a fourth wavelength of light is used which is extinguished substantially differently by oxyhemoglobin and reduced hemoglobin and which is not substantially extinguished by plasmas, then the blood oxygen saturation value, independent of hematocrit, maybe determined. It is also disclosed how to detect and analyze multiple wavelengths using a logarithmic DC analysis technique. Then a pulse wave is not required.


David A Harris Photo 3

David A Harris, Ogden UT - CSW

Specialties:
Social Work
Address:
237 26Th St, Ogden 84401
(801) 778-6856 (Phone)
Languages:
English


David Harris Photo 4

System And Method For Noninvasive Hematocrit Monitoring

US Patent:
5372136, Dec 13, 1994
Filed:
Feb 1, 1993
Appl. No.:
8/011882
Inventors:
Robert R. Steuer - Pleasant View UT
David H. Harris - Ogden UT
Assignee:
Noninvasive Medical Technology Corporation - Ogden UT
International Classification:
A61B 500
US Classification:
128633
Abstract:
A system for determining the hematocrit transcutaneously and noninvasively. Disclosed are a finger clip assembly and an earlobe clip assembly, each including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least two, and preferably three, predetermined wavelengths of light are passed onto or through body tissues such as the finger, earlobe, or scalp, etc. and the extinction of each wavelength is detected. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If a fourth wavelength of light is used which is extinguished substantially differently by oxyhemoglobin and reduced hemoglobin and which is not substantially extinguished by plasma, then the blood oxygen saturation value, independent of hematocrit, may be determined. It is also disclosed how to detect and analyze multiple wavelengths using a logarithmic DC analysis technique. Then a pulse wave is not required so, this method may be utilized in states of low blood pressure or low blood flow.


David Harris Photo 5

System For Noninvasive Hematocrit Monitoring

US Patent:
5803908, Sep 8, 1998
Filed:
Jun 7, 1995
Appl. No.:
8/479352
Inventors:
Robert R. Steuer - Pleasant View UT
David H. Harris - Ogden UT
Assignee:
In-Line Diagnostics Corporation - Riverdale UT
International Classification:
A61B 500
US Classification:
600314
Abstract:
A system for determining the hematocrit transcutaneously and noninvasively. Disclosed are a finger clip assembly and an earlobe clip assembly, each including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least two, and preferably three, predetermined wavelengths of light are passed onto or through body tissues such as the finger, earlobe, or scalp, etc. and the extinction of each wavelength is detected. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If a fourth wavelength of light is used which is extinguished substantially differently by oxyhemoglobin and reduced hemoglobin and which is not substantially extinguished by plasma, then the blood oxygen saturation value, independent of hematocrit, may be determined. It is also disclosed how to detect and analyze multiple wavelengths using a logarithmic DC analysis technique. Then a pulse wave is not required.


David Harris Photo 6

Disposable Extracorporeal Conduit For Blood Constituent Monitoring

US Patent:
5351686, Oct 4, 1994
Filed:
May 24, 1993
Appl. No.:
8/066344
Inventors:
Robert R. Steuer - Pleasant View UT
David H. Harris - Ogden UT
Assignee:
In-Line Diagnostics Corporation - Ogden UT
International Classification:
A61B 500
US Classification:
128633
Abstract:
A disposable cuvette through which to pass pulsatile flowing blood. The cuvette has a conduit with two opposed walls having a predetermined separation therebetween that varies with each pulse of the flowing blood. A sealed air pocket damps the variation of the predetermined separation. The conduit is comprised of materials which permit passage therethrough of wavelengths of selected electromagnetic radiation. The radiation is emitted from a photoemitter which, and after passing through the cuvette, is detected by a photodetector. The quantities of detected radiation are operated on by a computer which uses a spectrophotometry technique to derive therefrom a blood constituent concentration value. Preferably, both cuvette and spectrophotometry technique are used during hemodialysis to derive changes in the hematocrit value of the blood of a dialyzed patient, thereby to deduce therefrom changes in the blood volume of the patient during dialysis. The technique enables a clinician to monitor a desired biologic constituent concentration value, such as the hematocrit, oxygen saturation, or oxygen content values by deriving and displaying the same as digital values in real time.


David Harris Photo 7

Disposable Extracorporeal Conduit For Blood Constituent Monitoring

US Patent:
5456253, Oct 10, 1995
Filed:
Sep 27, 1994
Appl. No.:
8/312712
Inventors:
Robert R. Steuer - Pleasant View UT
David H. Harris - Ogden UT
Assignee:
In-Line Diagnostics Corporation - Riverdale UT
International Classification:
A61B 500
US Classification:
128633
Abstract:
A disposable cuvette through which to pass pulsatile flowing blood. The cuvette has a conduit with two opposed walls having a predetermined separation therebetween that varies with each pulse of the flowing blood. A sealed air pocket damps the variation of the predetermined separation. The conduit is comprised of materials which permit passage therethrough of wavelengths of selected electromagnetic radiation. The radiation is emitted from a photoemitter which, and after passing through the cuvette, is detected by a photodetector. The quantities of detected radiation are operated on by a computer which uses a spectrophotometry technique to derive therefrom a blood constituent concentration value. Preferably, both cuvette and spectrophotometry technique are used during hemodialysis to derive changes in the hematocrit value of the blood of a dialyzed patient, thereby to deduce therefrom changes in the blood volume of the patient during dialysis. The technique enables a clinician to monitor a desired biologic constituent concentration value, such as the hematocrit, oxygen saturation, or oxygen content values by deriving and displaying the same as digital values in real time.


David Harris Photo 8

System For Noninvasive Hematocrit Monitoring

US Patent:
6266546, Jul 24, 2001
Filed:
May 28, 1998
Appl. No.:
9/084958
Inventors:
Robert R. Steuer - Pleasant View UT
David H. Harris - Ogden UT
Assignee:
In-Line Diagnostics Corporation - Riverdale UT
International Classification:
A61B 500
US Classification:
600322
Abstract:
A system for determining the hematocrit transcutaneously and noninvasively. Disclosed are a finger clip assembly and an earlobe clip assembly, each including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least two, and preferably three, predetermined wavelengths of light are passed onto or through body tissues such as the finger, earlobe, or scalp, etc. and the extinction of each wavelength is detected. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If a fourth wavelength of light is used which is extinguished substantially differently by oxyhemoglobin and reduced hemoglobin and which is not substantially extinguished by plasma, then the blood oxygen saturation value, independent of hematocrit, may be determined. It is also disclosed how to detect and analyze multiple wavelengths using a logarithmic DC analysis technique. Then a pulse wave is not required.


David Harris Photo 9

System For Noninvasive Hematocrit Monitoring

US Patent:
5499627, Mar 19, 1996
Filed:
Oct 4, 1994
Appl. No.:
8/317726
Inventors:
Robert R. Steuer - Pleasant View UT
David H. Harris - Ogden UT
Assignee:
In-Line Diagnostics Corporation - Riverdale UT
International Classification:
A61B 500
US Classification:
128633
Abstract:
A system for determining the hematocrit transcutaneously and noninvasively. Disclosed are a finger clip assembly and an earlobe clip assembly, each including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mode. At least two, and preferably three, predetermined wavelengths of light are passed onto or through body tissues such as the finger, earlobe, or scalp, etc. and the extinction of each wavelength is detected. Mathematical manipulation of the detected values compensates for the effects of body tissue and fluid and determines the hematocrit value. If a fourth wavelength of light is used which is extinguished substantially differently by oxyhemoglobin and reduced hemoglobin and which is not substantially extinguished by plasma, then the blood oxygen saturation value, independent of hematocrit, may be determined. It is also disclosed how to detect and analyze multiple wavelengths using a logarithmic DC analysis technique. Then a pulse wave is not required.